| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2119065 | Cancer/Radiothérapie | 2006 | 9 Pages |
Abstract
In order to support adoption and dissemination into clinical practice of innovative treatment strategies, being almost by definition more expensive than the corresponding standard treatments, an appropriate reimbursement is a prerequisite. This article describes different possible financing systems in the context of technological advances in radiation oncology and analyses if and how the reimbursement issue has been tackled in European radiotherapy centres.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Y. Lievens,